MedPath

Vor Biopharma

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
168
Market Cap
$60.8M
Website
Introduction

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.

Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

Phase 1
Active, not recruiting
Conditions
Leukemia, Myeloid, Acute
Interventions
First Posted Date
2023-08-09
Last Posted Date
2025-05-14
Lead Sponsor
Vor Biopharma
Target Recruit Count
38
Registration Number
NCT05984199
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California San Diego Moores Cancer Center, La Jolla, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Stanford Cancer Institute, Stanford, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Miami Cancer Institute, Miami, Florida, United States

and more 11 locations

A Long-term Follow-up Study of Patients Who Received VOR33

Active, not recruiting
Conditions
Leukemia, Myeloid, Acute
Interventions
Genetic: VOR33
First Posted Date
2022-04-04
Last Posted Date
2025-05-14
Lead Sponsor
Vor Biopharma
Target Recruit Count
10
Registration Number
NCT05309733
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California San Diego Moores Cancer Center, La Jolla, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Miami Cancer Institute, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health, Clinical Center, Bethesda, Maryland, United States

and more 8 locations

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Phase 1
Active, not recruiting
Conditions
Leukemia, Myeloid, Acute
Myelodysplastic Syndromes
Interventions
First Posted Date
2021-04-19
Last Posted Date
2025-05-15
Lead Sponsor
Vor Biopharma
Target Recruit Count
67
Registration Number
NCT04849910
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California San Diego Moores Cancer Center, La Jolla, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Stanford Cancer Institute, Stanford, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Miami Cancer Institute, Miami, Florida, United States

and more 12 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath